TipRanks
Advertisement
Advertisement

RNAZ Stock Latest News

TransCode Therapeutics Eases Near-Term Obligations Under Financing
Company AnnouncementsTransCode Therapeutics Eases Near-Term Obligations Under Financing
10d ago
8K
RNAZ
TransCode Highlights Promising Phase 1a Results for TTX-MC138
PremiumCompany Announcements
TransCode Highlights Promising Phase 1a Results for TTX-MC138
13d ago
8K
RNAZ
Transcode Therapeutics reports updated results from Phase 1a TTX-MC138 trial
PremiumThe Fly
Transcode Therapeutics reports updated results from Phase 1a TTX-MC138 trial
13d ago
RNAZ
Transcode Therapeutics announces patent advancements in Australia and Japan
PremiumThe Fly
Transcode Therapeutics announces patent advancements in Australia and Japan
19d ago
RNAZ
Transcode Therapeutics announces patent advancements in Australia and Japan
PremiumThe Fly
Transcode Therapeutics announces patent advancements in Australia and Japan
19d ago
RNAZ
TransCode Therapeutics Announces CFO Resignation and Interim Appointment
PremiumCompany AnnouncementsTransCode Therapeutics Announces CFO Resignation and Interim Appointment
30d ago
8K
RNAZ
Transcode Therapeutics CFO Fitzgerald retiring, Tattory named interim CFO
Premium
The Fly
Transcode Therapeutics CFO Fitzgerald retiring, Tattory named interim CFO
1M ago
RNAZ
Transcode Therapeutics announces publication of article on TTX-MC138
Premium
The Fly
Transcode Therapeutics announces publication of article on TTX-MC138
1M ago
RNAZ
TransCode Therapeutics Updates Preferred Stock Governance Terms
PremiumCompany Announcements
TransCode Therapeutics Updates Preferred Stock Governance Terms
2M ago
8K
RNAZ
TransCode Therapeutics Shareholders Approve Key Capital Measures
PremiumCompany Announcements
TransCode Therapeutics Shareholders Approve Key Capital Measures
3M ago
8K
RNAZ
TransCode Therapeutics Updates Preferred Stock Ownership Limits
PremiumCompany Announcements
TransCode Therapeutics Updates Preferred Stock Ownership Limits
3M ago
8K
RNAZ
TransCode Adjourns Annual Meeting Amid Nasdaq Listing Steps
PremiumCompany Announcements
TransCode Adjourns Annual Meeting Amid Nasdaq Listing Steps
3M ago
8K
RNAZ
TransCode Highlights Progress of Lead RNA Cancer Therapeutic
PremiumCompany AnnouncementsTransCode Highlights Progress of Lead RNA Cancer Therapeutic
4M ago
8K
RNAZ
Transcode reports results from Phase 1a dose escalation trial with TTX-MC138
Premium
The Fly
Transcode reports results from Phase 1a dose escalation trial with TTX-MC138
4M ago
RNAZ
TransCode Therapeutics Advances TTX-MC138 After Positive Phase 1a
Premium
Company Announcements
TransCode Therapeutics Advances TTX-MC138 After Positive Phase 1a
4M ago
8K
RNAZ
TransCode Sets Key Deadlines for 2026 Shareholder Meeting
PremiumCompany Announcements
TransCode Sets Key Deadlines for 2026 Shareholder Meeting
4M ago
8K
RNAZ
Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138
PremiumThe Fly
Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138
5M ago
RNAZ
TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice
PremiumCompany Announcements
TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice
5M ago
8K
RNAZ
Transcode Therapeutics files to sell 1.53M shares of common stock for holders
PremiumThe Fly
Transcode Therapeutics files to sell 1.53M shares of common stock for holders
5M ago
RNAZ
Transcode Therapeutics files to sell 15.96M shares of common stock for holders
PremiumThe FlyTranscode Therapeutics files to sell 15.96M shares of common stock for holders
5M ago
RNAZ
Transcode Therapeutics appoints Anna Moore as Chair of Scientific Advisory
Premium
The Fly
Transcode Therapeutics appoints Anna Moore as Chair of Scientific Advisory
6M ago
RNAZ
Transcode Therapeutics signs research agreement with Michigan State University
Premium
The Fly
Transcode Therapeutics signs research agreement with Michigan State University
6M ago
RNAZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >